◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › VCEL

Vericel Corporation (VCEL) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-07-10

Vericel Corporation (VCEL) operates in the Biotechnology industry and is headquartered in Burlington, United States with about 398 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, VCEL reported $276M in revenue and $16M in net income.

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America.

Interactive charts & full statements → Open the VCEL valuation workbench →

VCEL Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-31
Total Revenue$276M$237M$198M$164M
Gross Profit$206M$172M$136M$110M
Operating Income (EBIT)$11M$4M($6M)($17M)
Net Income$16M$10M($3M)($17M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

VCEL Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$68M$93M$68M$63M$53M
Gross Profit$49M$73M$50M$47M$36M
Operating Income (EBIT)($8M)$22M$4M($2M)($13M)
Net Income($6M)$23M$5M($1M)($11M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

VCEL Free Cash Flow History

VCEL Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-31
Total Assets$488M$433M$354M$273M
Total Liabilities$133M$141M$128M$81M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive VCEL viewer.

Other Companies in Biotechnology

← VCAll stocksVCIG →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.